SCHEMBL642926

SCHEMBL642926

CN(C)C(c1cccc(F)c1)C1CCC(CCNC(=O)c2c(N(C)S(=O)(=O)c3ccc(Cl)c(Cl)c3)sc3c2CCCC3)CC1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRL1 P41146 2/20 0.34
CNR2 P34972 2/20 0.34
LMNA P02545 5/20 0.34
ALDH1A1 P00352 3/20 0.34
HPGD P15428 3/20 0.34
MAPK1 P28482 3/20 0.34
NPSR1 Q6W5P4 2/20 0.34
KDM4E B2RXH2 2/20 0.34
MEN1 O00255 1/20 0.34
POLB P06746 1/20 0.34
KMT2A Q03164 1/20 0.34
KIF11 P52732 1/20 0.32
GAA P10253 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
PSEN1 P49768 2/20 0.32
PSEN2 P49810 2/20 0.32
SPPL2A Q8TCT8 2/20 0.32
APH1B Q8WW43 2/20 0.32
NCSTN Q92542 2/20 0.32
APH1A Q96BI3 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL644426 0.93 LMNA (0.35) CNR2LMNAALDH1A1HPGDMAPK1
SCHEMBL643082 0.90 MAPT (0.36) CNR2LMNAALDH1A1HPGDMAPK1
SCHEMBL644323 0.87 KIF11 (0.39) CNR2LMNAALDH1A1HPGDMAPK1
SCHEMBL645036 0.82 KMT2A (0.42) OPRL1LMNAALDH1A1HPGDKMT2A
SCHEMBL2488269 0.76 PSEN1 (0.35) CNR2LMNAALDH1A1HPGDMAPK1
SCHEMBL2490758 0.76 SPPL2A (0.36) CNR2LMNAALDH1A1HPGDMAPK1
SCHEMBL644868 0.76 KMT2A (0.44) LMNAALDH1A1KMT2ASMN1; SMN2TP53
SCHEMBL645035 0.75 OPRL1 (0.37) OPRL1LMNAALDH1A1NPC1TACR3
SCHEMBL27751828 0.74 SCD (0.45) OPRL1NPC1RAB9A
SCHEMBL1328124 0.74 OPRL1 (0.42) OPRL1ALDH1A1NPC1RAB9ATACR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2150530-B1 SUBSTITUTED SULFONAMIDE DERIVATIVES GRUENENTHAL GMBH (DE) 2011-10-26 EP claimed
US-20080312231-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2008-12-18 US claimed
US-8119633-B2 N-{2-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-2-oxo-ethoxy]-ethyl}-N-ethyl-4-methoxy-2,3,6-trimethyl-phenylsulfonamide; condensing the N-carboxyalkyl phenylsulfonamide with the substituted piperidine; bradykinin receptor antagonists; analgesics; antidiabetics; angiogenesis inhibitors; rheumatic diseases GRUENENTHAL GMBH (DE) 2012-02-21 US disclosed
EP-2150530-B1 SUBSTITUTED SULFONAMIDE DERIVATIVES GRUENENTHAL GMBH (DE) 2011-10-26 EP disclosed
US-20080312231-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2008-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312231-A1 Substituted Sulfonamide Compounds SULT2A1, SULT1A1, SCN1A OPRL1 26/4885CNR2 51/4885LMNA 2721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.